For chromogenic ISH, Digoxigenin, compared to biotin, offers the advantage of lower background, higher specificity. Is also possible to combine dig- and biotin-labeling in multiplexing experiments, whether two different in situ probes are used with each other, or chromogenic ISH is combined with immunohistochemistry.

Leave a comment